Financial News

Financial Report: PAREXEL

Service revenues up 4% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL

2Q Revenues: $604.2 million (+5%)

2Q Earnings: $39.4 million (+2%)

YTD Revenues: $1.2 billion (+4%)

YTD Earnings: $64.3 million (-15%)

Comments: Service revenues were $518.5 million in the quarter, up 4%. Clinical Research Services (CRS) revenue was $407.1 million, PAREXEL Consulting (PC) sales were $41.4 million, and PAREXEL Informatics sales were $70.0 million. A restructuring charge of $10.4 million was recorded in the quarter related to PAREXEL’s ongoing Margin Acceleration Program.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters